Podcasts about commercializing

  • 204PODCASTS
  • 245EPISODES
  • 38mAVG DURATION
  • 1MONTHLY NEW EPISODE
  • May 28, 2025LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about commercializing

Latest podcast episodes about commercializing

The Tech Leader's Playbook
Climate Innovation That Actually Sells: No Green Premium Required

The Tech Leader's Playbook

Play Episode Listen Later May 28, 2025 52:00


In this episode of The Tech Leader's Playbook, Avetis Antaplyan interviews Josh Dorfman, a serial climate entrepreneur, about his journey into sustainability and the founding of Planted, a company focused on creating sustainable materials. They discuss the challenges of commercializing innovative solutions, the importance of scaling climate tech, and the role of media in raising awareness about climate action through Supercool, a platform that highlights successful climate tech stories. In this conversation, Josh and Avetis explore the intersection of climate technology and business, emphasizing the importance of commercializing sustainability. They discuss the role of AI in driving innovative solutions, the need to make climate solutions appealing to consumers, and the significance of effective messaging in the clean tech sector. The conversation also touches on the challenges posed by rare earth minerals in the clean energy transition and the potential of urban mining and recycling to address these issues. Ultimately, they highlight the urgency of engaging with climate innovation and the need for actionable solutions in the face of climate change.TakeawaysJosh Dorfman's journey into sustainability began in China.The need for practical solutions to climate change is urgent.Planted aims to replace traditional materials with sustainable alternatives.Commercializing innovative materials presents numerous challenges.The vision for Planted is to create a carbon removal machine.Supercool was created to highlight successful climate tech stories.Investments in clean energy are outpacing fossil fuels.The importance of scaling climate tech solutions is critical.Understanding the core innovation of climate tech is essential.Media plays a vital role in raising awareness about climate solutions.AI is increasingly integrated into climate tech solutions.Making climate solutions appealing is crucial for adoption.Effective messaging should focus on business value, not just sustainability.The clean energy transition relies on critical minerals.Urban mining presents a novel solution for resource recovery.Engaging with climate innovation requires understanding customer needs.Energy efficiency is becoming a priority in climate solutions.Necessity drives innovation in recycling and clean tech.The time for climate action is now.Chapters00:00 Introduction to Climate Innovation01:18 Josh's Journey into Sustainability06:36 Founding Planted: A New Approach to Materials09:42 Challenges in Commercializing Sustainable Materials14:07 The Vision Behind Planted's Innovation20:40 Transitioning to Media: The Birth of Supercool24:25 Choosing Stories for Climate Tech Awareness26:57 Commercializing Sustainability28:51 AI in Climate Tech Innovation31:01 Making Climate Solutions Appealing32:16 Selling Sustainability Effectively35:47 The Role of Technology in Clean Energy39:55 Rare Earths and Clean Tech Boom44:22 Recycling and Urban Mining Solutions46:14 Engaging with Climate Innovation48:41 The Time for Climate ActionJosh Dorfman's Social Media Links:https://www.linkedin.com/in/dorfmanjosh/https://x.com/Josh_DorfmanJosh Dorfman's Website:https://supercool.beehiiv.com/

Business Of Biotech
Commercializing RNAi Therapies With Alnylam's Tolga Tanguler

Business Of Biotech

Play Episode Listen Later May 5, 2025 55:54 Transcription Available


We love to hear from our listeners. Send us a message. On today's episode, Tolga Tanguler, EVP and Chief Commercial Officer at Alnylam Pharmaceuticals, talks about commercializing RNAi therapies, how they fit into health insurance reimbursement systems, the company's use of value-based contracts, and building therapeutic franchise "skyscrapers." Tangular also shares his thoughts on commercializing RNAi therapies for larger patient populations, compared with rare disease populations, and reflects on changes in the biopharmaceutical sales and promotion model.This episode is brought to you by Avantor. For more information, visit avantorsciences.comAccess this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

The Mobility Standard
Solomon Islands Says CBI “a Long Way Off” and Rejects “Commercializing” Citizenship

The Mobility Standard

Play Episode Listen Later May 5, 2025 3:01


The government has expressed concerns about foreign agents' influence, and “strongly rejects any arrangement that compromises sovereignty.”View the full article here.Subscribe to the IMI Daily newsletter here.

Xtalks Life Science Podcast
From Lab to Launch: Commercializing Gene Therapies for Rare Diseases with Rocket Pharma's Carlos Martin

Xtalks Life Science Podcast

Play Episode Listen Later Apr 9, 2025 33:54


In this episode, Ayesha spoke with Carlos Martin, MBA, chief commercial operations and revenue officer at Rocket Pharmaceuticals, a company developing gene therapy cures for rare diseases through innovative science and platforms. Carlos joined Rocket in April 2021 and established the company's early commercial strategy and infrastructure as Chief Commercial Officer. Prior to joining Rocket, Carlos was the US Commercial Head of Advanced Accelerator Applications (AAA), a Novartis Oncology Company. His responsibilities included leading commercial strategy and new product launches as well as transforming their go-to-market model. Carlos brings in-depth background and experience globally and locally in commercial strategy and operations across a wide range of modalities and disease areas, including oncology, cardiovascular, metabolism and complex therapeutics. Carlos has a bachelor's degree in economics from ESADE & the Polytechnic University of Barcelona, Spain and an MBA from the Thunderbird School of Global Management at Arizona State University. Tune in to hear from Carlos about the challenges and opportunities in the commercialization of gene therapies for rare diseases. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

CORE Knowledge
GEORG | Sigurdur Markusson on CORE Knowledge Podcast

CORE Knowledge

Play Episode Listen Later Feb 24, 2025 48:10


Innovation is at the heart of the energy industry and with geothermal it is no different. Sigurdur Markusson has been involved in a variety of projects that have dealt with harvesting geothermal energy and using it to sustainably produce food and now takes over the role of managing director at GEORG. It is time for collaboration, innovation, and awareness to accelerate for the geothermal industry. GEORGhttps://www.linkedin.com/company/georg-geothermal-research-cluster/about/Sigurdur Markussonhttps://www.linkedin.com/in/sigurdur-h-markusson-8b979729/CORE Knowledgehttps://www.linkedin.com/company/core-geothermalNick Cestari https://www.linkedin.com/in/nick-cestari-48059268/

Farm and Ranch Report
Commercializing Ag Research

Farm and Ranch Report

Play Episode Listen Later Feb 5, 2025


The success of American agriculture has come in no small part from the contributions of research and extension, but commercializing those solutions still needs improvement.

Automate Construction Podcast
Pikus 3D CEO on Commercializing 3D Printed Concrete

Automate Construction Podcast

Play Episode Listen Later Feb 3, 2025 76:49


Darren and I dive into the history of Pikus 3D, its origins from a traditional concrete company to where it is today. We talk about how the lead founder Rob Pikus built a company that was able to continue growing even after he passed away. Routing episode is the best I've done to date and provides a much needed. Look at what Gun Pike as to where it is today. This episode is the best I've done to date and provides a much needed look at what got Pikus 3D to where it is today. I'm looking forward to the next installment of the series. https://www.pikus3d.com/ https://www.automateconstruction.com

SHIFT
Commercializing Our Space Age Future

SHIFT

Play Episode Listen Later Jan 8, 2025 17:47


A live conversation about the state of the space industry with serial space entrepreneur Kam Ghaffarian, a co-founder of Axiom Space, Intuitive Machines, Quantum Space, and more, from the mainstage at Collision Conference in Toronto, Canada.This episode first published on June 26th, 2024. We meet: Dr. Kamal "Kam" GhaffarianCredits:This episode of SHIFT was produced by Jennifer Strong and Emma Cillekens, and it was mixed by Garret Lang, with original music from him and Jacob Gorski. Art by Meg Marco.

The Gary DeMar Podcast
On Commercializing Christmas

The Gary DeMar Podcast

Play Episode Listen Later Dec 25, 2024 15:38


Too much time and money, we hear, are spent on the public side of Christmas — the hustle and bustle of shopping, the lavish decorations, and the often insincere displays of seasonal piety. Meanwhile, the true spirit of Christmas gets left behind. Some even argue that all public displays of Christmas are inappropriate. Read the article on the American Vision website: https://americanvision.org/posts/let-s-keep-christmas-commercialized/

COSMOFACTORY
Commercializing a New Brand, featuring ProBeauty Partners CEO and Founder Adrienne Kramer

COSMOFACTORY

Play Episode Listen Later Dec 24, 2024 24:20


Creating a beauty brand and crafting a product line takes a lot of work. What comes next—ensuring that your brand resonates with the market and generates revenue—is perhaps even more challenging.  This week on the CosmoFactory podcast, we explore market readiness and how indie beauty brand leaders can be ready to meet with retail buyers and begin to build the relationships that will unlock success in the marketplace. Our guest is Adrienne Kramer, CEO and Founder of ProBeauty Partners, a US–based business consultancy that's been working with emerging brands for nearly 15.   If you appreciated this episode: SHARE it with a friend, SUBSCRIBE to the CosmoFactory podcast & please LEAVE US A REVIEW today. With your help, even more cosmetic industry professionals can discover the inspiring interviews we share on CosmoFactory! ABOUT CosmoFactoryBeauty industry stakeholders listen to the CosmoFactory podcast for inspiration and for up-to-date information on concepts, tactics, and solutions that move business forward. CosmoFactory – Ideas to Innovation is a weekly interview series for cosmetics and personal care suppliers, finished product brand leaders, retailers, buyers, importers, and distributors. Each Tuesday, CosmoFactory guests share experiences, insights, and exclusive behind-the-scenes details—which makes this not only a must-listen B2B podcast but an ongoing case study of our dynamic industry. Guests are actively working in hands-on innovation roles along the beauty industry supply chain; they specialize in raw materials, ingredients, manufacturing, packaging, and more. They are designers, R&D or R&I pros, technical experts, product developers, key decision makers, visionary executives. HOST Deanna UtroskeCosmetics and personal care industry observer Deanna Utroske hosts the CosmoFactory podcast. She brings an editorial perspective and a decade of industry expertise to every interview. Deanna is also Editor of the Beauty Insights newsletter and a supply-side positioning consultant. She writes the Global Perspectives column for EuroCosmetics magazine, is a former Editor of CosmeticsDesign, and is known globally for her ability to identify emerging trends, novel technologies, and true innovation in beauty. A PRODUCTION OF Cosmoprof Worldwide BolognaCosmoFactory is the first podcast from Cosmoprof Worldwide Bologna, taking its place among the best B2B podcasts serving the global beauty industry.   Cosmoprof Worldwide Bologna is the most important beauty trade show in the world. Dedicated to all sectors of the industry, Cosmoprof Worldwide Bologna welcomes over 250,000 visitors from 150 countries and regions and nearly 3,000 exhibitors to Bologna, Italy, each year. It's where our diverse and international industry comes together to build business relationships and to discover the best brands and newest innovations across consumer beauty, professional beauty, and the entire supply chain. The trade show includes a robust program of exclusive educational content, featuring  executives and key opinion leaders from every sector of the cosmetics, fragrance, and personal care industry. Cosmoprof Worldwide Bologna is the most important event of the Cosmoprof international network, with exhibitions in Asia (Hong Kong), the US (Las Vegas and Miami), India (Mumbai) and Thailand (Bangkok). Thanks to its global exhibitions Cosmoprof connects a community of more than 500,000 beauty stakeholders and 10,000 companies from 190 countries and regions. Learn more today at Cosmoprof.com   

The Green Building Matters Podcast with Charlie Cichetti
Decarbonization Through BIM-Based Solutions with Michael Gustafson

The Green Building Matters Podcast with Charlie Cichetti

Play Episode Listen Later Dec 4, 2024 41:52


  Michael is a seasoned business strategist in the AEC tech sector with a focus on structural engineering and fabrication. He practiced as a structural engineer at Ellerbe Becket, holds an MS in Civil Engineering, an MBA from Michael J. Coles College of Business and is a Professional Engineer from California. He is also certified in AI for Business Managers from MIT. Michael Gustafson is an Innovative business strategist with a demonstrated history of impactful change in the architecture, engineering and construction sector.  Customer-centric professional skilled in Strategic Planning, Sales, Marketing, Product Management, Go-to-Market Strategy and Strategic Partnerships. Michael has deep industry and technology expertise in Structural Engineering, Building Information Modeling and AI/Generative Design.  Proven leader that inspires others to create success. Passionate about reducing the carbon footprint of our built environment to address climate change. Show Highlights   Reducing embodied carbon in construction for mitigating climate change and achieving sustainability goals. The potential of AI in concrete and steel optimization to analyze vast datasets. Commercializing cost-carbon analysis for steel connections. Interactive design optimization to minimize waste in steel connections while maintaining necessary standardization for ease of construction. Sublime Systems and Carbon Cure innovations in concrete space. Highlights Nucor's efforts in using nuclear energy for steel production. Expresses concern about embodied carbon in global construction. The industries need international cooperation in reducing embodied carbon.   “Over the last two years, we've been making a slight shift with the technology to be more focused upstream because we've seen the impact on reducing waste inefficiency as well as better carbon planning, focusing more on owners, general contractors, and structural engineers. Recently we've released new technologies integrated on Autodesk Revit.”   Show Resource and Information Connect with Charlie Cichetti and GBES   GBES is excited our membership community is growing. Consider joining our membership community as members are given access to some of the guests on the podcasts that you can ask project questions. If you are preparing for an exam, there will be more assurance that you will pass your next exam, you will be given cliff notes if you are a member, and so much more. Go to to learn more about the 4 different levels of access to this one-of-a-kind career-advancing green building community!   If you truly enjoyed the show, don't forget to leave a positive rating and review on .  We have prepared more episodes for the upcoming weeks, so come by again next week! Thank you for tuning in to the !   Copyright © 2024 GBES

CORE Knowledge
World Geothermal Energy Day | Blue Spark and Microseismic on CORE Knowledge Podcast

CORE Knowledge

Play Episode Listen Later Nov 25, 2024 27:28


World Geothermal Energy Day 2024 - CORE Knowledge got to be a part by helping to raise awareness, be a voice and spread educational content around geothermal and what roles it can play in the energy ecosystem of today and tomorrow. I sit down with Jason Fisher from Blue Spark and Peter Duncan from Microseismic to cover a variety of topics from why they love geothermal to how it has changed the way we look at decarbonizing the globe.  Blue Spark https://www.linkedin.com/company/bluesparkenergy/Jason Fisher https://www.linkedin.com/in/geothermal-fisher/Microseismichttps://www.linkedin.com/company/microseismicinc/posts/?feedView=allPeter Duncan https://www.linkedin.com/in/petermduncan/CORE Knowledgehttps://www.linkedin.com/company/core-geothermalNick Cestari https://www.linkedin.com/in/nick-cestari-48059268/Gallanthttps://www.linkedin.com/company/gallantculture/posts/?feedView=all

RBC Disruptors
Commercializing Space (Part 2): From Frontier to Marketplace

RBC Disruptors

Play Episode Listen Later Nov 21, 2024 27:56


Part two of Disruptors x CDL: The Innovation Era continues with a focus on how space technology is transitioning from exploration to commercial viability.John Stackhouse and Sonia Sennik are joined by aerospace leaders Christine Tovee, former CTO of Airbus Group North America, and Mina Mitry, CEO of Kepler Communications. The episode examines the pioneering role of Canadian companies in transforming space technologies into practical industries, such as satellite communications and Earth observation.

Category Visionaries
Matthew Kinsella, CEO of Infleqtion: $150 Million Raised to Build the Future of Quantum Technology

Category Visionaries

Play Episode Listen Later Oct 18, 2024 37:17


Welcome to another episode of Category Visionaries — the show that explores GTM stories from tech's most innovative B2B founders. In today's episode, we're speaking with Matthew Kinsella, CEO of Infleqtion, a quantum technology company that's raised over $150 Million in funding. Here are the most interesting points from our conversation: Quantum technology's roots at CU Boulder: Infleqtion's journey started with foundational research from Nobel Prize-winning physicists at CU Boulder. They developed ways to control atoms using lasers, which unlocked the ability to isolate and exploit quantum properties for next-gen tech applications. The unexpected career shift: Matthew spent nearly two decades as an investor, never planning to run a company. His deep dive into quantum technology in 2017 led him to invest in Infleqtion, and ultimately to step in as CEO, driven by the technology's potential to be transformative for humanity and national security. Explaining quantum to grandma: When simplifying quantum technology, Matthew compares it to Newtonian physics but highlights that quantum operates with its own set of bizarre rules, where everything is governed by probabilities, and phenomena like superposition and entanglement defy everyday logic. Commercializing quantum tech: Infleqtion is already selling products like their quantum optical clock, which keeps time 1,000 times more accurately than anything currently available. This tech has wide-reaching implications, from improving GPS accuracy to enabling future quantum computers. The race to quantum supremacy: Quantum computing is still a few years away from reaching "quantum advantage," but Matthew believes that within five years, we'll see quantum computers outperform classical computers in specific tasks. Meanwhile, quantum sensors and clocks are already delivering commercial value today. Navigating government contracts: Matthew shares that breaking into government procurement is complex and involves building relationships through programs like SBIR grants. Success in this space can be transformative, with multi-year contracts that provide a consistent revenue stream.   //   Sponsors: Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe.  www.GlobalTalent.co    

Farm and Ranch Report
Commercializing University Research - Part Two

Farm and Ranch Report

Play Episode Listen Later Aug 29, 2024


Jackson Stansell's research on fertigation in irrigated corn led him to put his Ph.D. on hold to build a company around it.

Farm and Ranch Report
Commercializing University Research

Farm and Ranch Report

Play Episode Listen Later Aug 28, 2024


Why doesn't more agricultural research at the university level lead to commercialized products?

Leaders on a Mission
Combat Microplastics: Discover Biodegradable Innovations

Leaders on a Mission

Play Episode Listen Later Aug 20, 2024 41:45


Harshal Chokhawala, the CEO of ZymoChem, breaks down their exciting solutions to microplastics. In this episode, we explore ZymoChem's groundbreaking efforts to decarbonize the production of everyday materials, providing real solutions to microplastics in the ocean, our bodies and the earth.  

SalesDNA: Decoding life science sales
[Science] Networking, cold calling, and commercializing with Saleha Patel

SalesDNA: Decoding life science sales

Play Episode Listen Later Aug 20, 2024 37:31


Takeaways - Prospecting to land scientific roles- Networking is critical for success- ELRIG events are a great way to network- Write personalized and relevant outreachSaleha Patelhttps://www.linkedin.com/in/patel-salehaDownload the life science sales rep toolkit: https://www.succession.bio/content/life-science-sales-toolkitAsk us anything: https://forms.gle/6cJJo7imyekPcwdEA About Succession: A life science sales training and community platform led by the top sales experts in the industry.- Get instant access to hours of on-demand and live training content.- Access to 100s of resources and tools- Network and learn from other growth-minded life science sales repsJoin Succession: https://www.succession.bio/join

Future of Mobility
#220 – Barry Jones | Provizio - Commercializing an Innovative Mobility Technology & 4D Imaging Radar

Future of Mobility

Play Episode Listen Later Aug 12, 2024 50:29


Barry Jones, strategic sales lead at Provizio, shares his insights on navigating the automotive industry and building successful businesses. He emphasizes the importance of understanding customer needs and solving multiple problems with one solution. Jones discusses the value proposition of Provisio's 4D imaging radar technology, which offers superior performance at a lower cost compared to traditional radar and lidar systems. He also highlights the significance of passion and a clear vision in driving business growth. Jones advises staying current with industry trends and understanding cultural differences when engaging with customers Key topics in this conversation include: The impact of Provizio's 4D imaging radar Finding the right access point to introduce new technology at OEMs Discovering the right business model How to successfully commercialize a new technology Answering two key questions: What problems are you solving for the customer? Do they care? Links: Show notes: http://brandonbartneck.com/futureofmobility/barryjones Edison Manufacturing Exchange: https://brandonbartneck.substack.com/publish/home LinkedIn (https://www.linkedin.com/company/proviz-io/) Website (https://provizio.ai/).  Bio Barry is responsible for strategic activities at Provizio to deliver full and proper development of several high value-added company objectives. Core activities are centered on achieving success as part of the NVIDIA reference architecture, as a reference partner to Texas Instrument, as a development partner with key OEM's/Tier 1's (such as JLR and Magna) and establishing an OEM footprint for Provizio in Japan. Prior to taking this role, Barry was Chief Engineer at Sanyo Trading leading their future technology activities including their ADAS strategy. Before this responsibility Barry was President of North American Operations and Global CTO for the Leggett and Platt Automotive Group leading P&L and technical activities for a leading Tier 1.5 electro-mechanical enterprise. During his tenure, Barry played a key role in growing the private company (Schukra) that became the base of the Automotive Group from a $60M USD company to a global $1.2B USD market leader over a 22-year period. Before joining Schukra Barry held various operational and senior engineering roles at General Motors both in Canada and the US (Detroit) for 12 years. End responsibility was Engineering Manager for Buick, Oldsmobile and Cadillac designing and launching seat interiors at GM headquarters in Detroit. About Provizio: Founded by a team of automotive and aerospace industry veterans, Provizio is the leading provider of low-cost advanced perception imaging radar that is reliable in all-weather conditions. Provizio is dedicated to balancing the system cost of radar and addressing the challenge of small object detection at range, delivering solutions for safe, cost-effective and scalable L3+ autonomy. At the core of Provizio's offerings are the VizioPrime 6K, the first market-ready solution to make LiDAR optional for L3+ autonomy applications, and 5D Perception® Driving Platform integrating GPU-based edge AI to fuse proprietary 5D Radar with vision systems and top-tier sensors, enabling real-time predictive analytics for safer driving. Future of Mobility: The Future of Mobility podcast is focused on the development and implementation of safe, sustainable, effective, and accessible mobility solutions, with a spotlight on the people and technology advancing these fields. Edison Manufacturing and Engineering: Edison is your low volume contract manufacturing partner, focused on assembly of complex mobility and energy products that don't neatly fit within traditional high-volume production methods. linkedin.com/in/brandonbartneck/ brandonbartneck.com/futureofmobility/

Crafted
How Media Is Made Today: AI and a Modern CMS | Matt Monahan, President, Arc XP, The Washington Post

Crafted

Play Episode Listen Later Aug 6, 2024 27:32


Making media is hard. Distributing it to the right audience even more so. GenAI can help. Matt Monahan is the president of Arc XP at the Washington Post. On this episode, we're digging into the core technology of any media company: the content management system (CMS), why they're so hard to build right and how new GenAI tools can reduce the toil required for journalists to get their stories to the right audience. Arc XP is not only the CMS used by the Washington Post, but it's also used by many other publishers, broadcasters, and companies with stories to tell. Matt shares more on the challenge of commercializing and white-listing an internal tool for others to use. It's a tantalizing idea – turn that cost center into a profit center! — but it's not for the faint of heart. Plus, lessons from Jeff Bezos, the owner of the Washington Post, including how the Post uses key Amazon practices, such as the “six page memo” and “one- and two-way doors.” Key Moments: (00:00) - Introduction (02:25) - From print to digital: hard product & organizational changes (04:17) - Why the CMS is where it all comes together (06:27) - Commercializing an internal tool: selling Arc XP to other publishers (10:07) - AWS and the impact of Jeff Bezos on the Washington Post (11:30) - The famous six-page memo and how the Post benefits from it (14:06) - GenAI: New features Matt is building to reduce toil for journalists (20:45) - How to pick the right model and fine tune it (23:24) - Matt's a pilot! What flying has taught him about running a business (24:33) - Being nimble: Why there are more “one way doors” than you think (26:07) - Outro CRAFTED. is brought to you in partnership with Docker, which helps developers build, share, run and verify applications anywhere – without environment confirmation or management. More than 20 million developers worldwide use Docker's suite of development tools, services and automations to accelerate the delivery of secure applications. CRAFTED. is produced by Modern Product Minds, where CRAFTED. host Dan Blumberg and team can help you take a new product from zero to one... and beyond. We specialize in early stage product discovery, growth, and experimentation. Learn more at modernproductminds.com Subscribe to CRAFTED., follow the show, and sign up for the newsletter

The VentureFuel Visionaries
Commercializing Emerging Tech - Yale Ventures Director of the Roberts Innovation Fund Claudia Reuter

The VentureFuel Visionaries

Play Episode Listen Later Jul 3, 2024 26:47


The Roberts Innovation Fund was launched in 2022 to provide funding, mentoring, and strategic support for Yale faculty-led projects to assist in the commercialization of breakthrough inventions that solve real-world problems. New methods to purify our water, advance quantum computing, democratize artificial intelligence, and deliver life-saving drugs are just some of the projects funded by the 2024 Roberts Innovation Fund Awards, providing $1 million in accelerator funding to support 10 new inventions led by faculty from Yale's School of Engineering & Applied Science. Director Claudia Reuter shares her insights on how to commercialize emerging technologies, how to innovation within a large organization.

EBRC In Translation
29. Commercializing CRISPR w/ Janice Chen

EBRC In Translation

Play Episode Listen Later Jul 1, 2024 37:54


In this episode, we speak with Janice Chen, co-founder and CTO of Mammoth Biosciences. From her PhD work in Jennifer Doudna's lab to co-founding a biotech startup, Dr. Chen discusses her journey of translating scientific discoveries into real-world applications. Learn about the development of CRISPR-based diagnostics, including a rapid COVID-19 test, and gain insights into the evolving landscape of gene editing therapeutics. Dr. Chen also offers valuable advice for scientists looking to bridge the gap between academia and industry.For more information about EBRC, visit our website at ebrc.org. If you are interested in getting involved with the EBRC Student and Postdoc Association, fill out a membership application for graduate students and postdocs or for undergraduates and join today!Episode transcripts are the unedited output from Whisper and likely contain errors.

SHIFT
Live: Commercializing Our Space Age Future

SHIFT

Play Episode Listen Later Jun 26, 2024 17:47


A live conversation about the state of the space industry with serial space entrepreneur Kam Ghaffarian, a co-founder of Axiom Space, Intuitive Machines, Quantum Space, and more, from the mainstage at Collision Conference in Toronto, Canada.We meet: Dr. Kamal "Kam" GhaffarianCredits:This episode of SHIFT was produced by Jennifer Strong and Emma Cillekens, and it was mixed by Garret Lang, with original music from him and Jacob Gorski. Art by Anthony Green.

The CleanTechies Podcast
#186 Electric Flight, Commercializing Hardware, Sustainable Aviation, Working at NASA, & More w/ Kevin Noertker (Ampaire)

The CleanTechies Podcast

Play Episode Listen Later Jun 22, 2024 48:25 Transcription Available


Kevin Noertker is the Co-Founder and CEO of Ampaire, a developer of Hybrid Aviation Propulsion Systems to Decarbonize Air Travel Today.Currently they are scaling up their tech. Their tech is proven to reduce fuel usage by about 50% for small aircrafts (anything with a propeller).Today, Kevin shares his story and we discuss:Aerospace Engineer to Ampaire: His story of co-founding Ampaire. Addressing Existing Stock: Electric aircraft is the future, but their solution helps address the existing stock of aircraft. Bridging the Infrastructure Gap: How fully electric air travel will require massive infrastructure upgrades, so they are building a solution that will work in between.Enjoy today's conversation! ---

LST's I Am The Law
From Lab to Law: Protecting and Commercializing Research

LST's I Am The Law

Play Episode Listen Later Jun 10, 2024 26:37 Transcription Available


Jenifer Slinskey manages the University of Pittsburgh's patent portfolio, a role that bridges the gap between academic research and industry commercialization. While this job does not require a law license, her STEM and patent law background improve the experience for the researchers she interfaces with and the outside patent counsel she manages. From submitting an invention disclosure form to collaborating with outside counsel, Jenifer outlines the rigorous process that transforms an inventor's academic idea into a commercial product. She provides an inside look at the collaborative effort required to protect and promote intellectual property at a leading research institution. Jenifer is a graduate of the University of Dayton School of Law.This episode is hosted by Katya Valasek.Mentioned in this episode:Learn more about Rutgers LawIdaho LawLearn more about Idaho LawLearn more about Rutgers LawIdaho LawLearn more about Idaho LawLearn more about Vermont LawAccess LawHub today!

Empowered to Grow
Ep. 173 - Bassem Kadry - Commercializing IPs: How to Productize Your Discovery

Empowered to Grow

Play Episode Listen Later Jun 5, 2024 32:30


In the latest episode of "Empowered to Grow in Business," I am thrilled to welcome Bassem Kadry, a visionary in the field of intellectual property and productization. Dive into an enlightening conversation on "Commercializing IPs: How to Productize Your Discovery."Discover the secrets behind transforming your innovative ideas into market-ready products. Bassem shares actionable insights and strategies that can help entrepreneurs and businesses navigate the complex journey from concept to commercialization.Tune in to learn:- The crucial steps for productizing intellectual properties- Common pitfalls to avoid- Real-life examples of successful productizationDon't miss this episode packed with valuable advice for entrepreneurs, business owners, and innovators aiming to turn their discoveries into successful ventures.

Systems Simplified
The Art of Commercializing Products and the Power of Processes With David Boyle

Systems Simplified

Play Episode Listen Later May 31, 2024 29:01


David Boyle is the Founder and Consultant at Boyle Brands, a package food and beverage consulting firm that provides leadership and technical support in supply chain and product development. As a 3x founder and serial entrepreneur, he has helped launch over 200 CPG product lines. David has worked with Fortune 500 companies and A-list celebrities and influencers in the natural food and beverage industry, specializing in commercializing products.  In this episode: Many entrepreneurs find themselves overwhelmed with tasks that could be delegated, caught in an endless loop of in-business activities. What does it take to break free from being the bottleneck of your company? How can you transition from a one-person show to an organized, expanding entrepreneurial venture? Having accidentally stumbled into entrepreneurship, David Boyle realized he had to reduce his company's reliance on him to scale further. As you gradually reduce your workload, David says to audit yourself to recognize where you spend your efforts. This will allow you to identify inefficiencies and tasks that can be systemized or delegated. When documenting and implementing systems, involve your team in the refinement process to enhance productivity and free yourself from the day-to-day. Join Adi Klevit in today's episode of Systems Simplified as she hosts David Boyle, the Founder and Consultant at Boyle Brands, who talks about systemizing business operations to foster company growth. David emphasizes the impact of having robust processes and procedures, the return on investment they present, and how they can free up the most valuable asset — time.

Future of Agriculture
FoA 417: Commercializing University Research For Better Nutrient Management | Phospholutions | Sentinel Fertigation

Future of Agriculture

Play Episode Listen Later May 29, 2024 36:33


Headstorm: https://headstorm.com/AGPILOT: https://headstorm.com/agpilot/Phospholutions: https://www.phospholutions.com/Sentinel Fertigation: https://www.sentinelfertigation.com/I'm a firm believer that in the U.S. our agricultural research and extension programs at our land grant universities truly are national treasures. But of all the outstanding research that's done at these institutions every year, not enough of it seems to get commercialized. Today we highlight two young entrepreneurs that each began their entrepreneurial journeys at their respective campuses, and are today growing real businesses helping farmers with different aspects of nutrient management. Today, you'll hear from Hunter Swisher, founder and CEO of Phospholutions which initially commercialized research done at Penn State. He does a great job talking about some of the major issues with the status quo when it comes to phosphorous. If you haven't looked into it before it's seriously eye opening. Then we'll move west to Nebraska, where Jackson Stensell formed his company Sentinel Fertigation based on research he was doing as a grad student at the University of Nebraska-Lincoln. He also focuses on nutrient management but specifically on irrigated crops. Hunter Swisher currently serves as the President and Chief Executive Officer of Phospholutions, Inc., which he founded prior to graduating with his B.S. degree in Plant Sciences from Pennsylvania State University. Phospholutions is a sustainable fertilizer company with the mission of improving global phosphate efficiency. Jackson Stansell is the founder and CEO of Sentinel Fertigation. Sentinel Fertigation leverages satellite imagery and geospatial data to empower precision nutrient management - particularly for nitrogen fertigation. Originally from Dothan, Alabama, Jackson did his undergrad at Harvard where he also played football. He was pursuing a masters degree at Nebraska when he turned the research he was doing into a business and decided to put his PhD on hold to commercialize the technology.

Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
Overcoming Skepticism When Commercializing Novel Therapies: Interview with Taopatch USA CEO Dmitri Leonov

Medsider Radio: Learn from Medical Device and Medtech Thought Leaders

Play Episode Listen Later May 23, 2024 52:12


In this episode of Medsider Radio, we had a fascinating chat with Dmitri Leonov, co-founder and CEO of Taopatch USA. The company is commercializing a range of wearable nanotechnology light therapy devices aimed at managing neurological conditions including pain management and sports performance.  Dmitri is also an advisor in a number of transformative technology projects. After seven fruitful years at Overture and later at Yahoo, he dove into the startup world. He went on to found several companies, including Sanebox.com, but was intrigued by frequency medicine and started his current venture by bringing Taopatch to the United States from Italy, where it was first invented.In this interview, Dmitri shares how the company was able to garner unique publicity and how strategic partnerships with holistic practitioners, authentic user testimonials, and a creative money-back guarantee strategy were instrumental in Taopatch USA's market success.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume V. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Dmitri Leonov.

Honey Hole Hangout - Your Favorite Fly Fishing and Hunting Podcast
Episode 164 - All About Fly Tying With Matt Bennett

Honey Hole Hangout - Your Favorite Fly Fishing and Hunting Podcast

Play Episode Listen Later May 22, 2024 92:42


FIND ALL OF OUR INFO HERE: https://linktr.ee/honeyholeangling   Follow Matt Bennett on Instagram: https://www.instagram.com/flygeekmatt/   Please leave us a review if you liked our podcast! Send us your thoughts, opinions, and concerns, or just say Hi! info@honeyholeangling.com   Summary In this conversation, the hosts and guests discuss various topics related to fly fishing and fly tying. They touch on the cost of fly tying, the challenges of starting a fly tying business, and the process of designing new fly patterns. The guest, Matt Bennett, shares his experience getting into fly fishing and fly tying, as well as his journey in starting his own fly tying business. He also talks about his popular fly patterns, such as the Lunch Money and the Rio Getter. In this part of the conversation, Matt Bennett discusses the limited number of materials available for fly tying and creating new fly patterns. He also talks about the commercialization of fly patterns and the importance of finding a community or mentor when starting in fly tying. Matt shares his top tips for new fly tiers, including investing in quality tools and materials. He also showcases some of his favorite tying tools, such as the Stonfo thread splitter and Dr. Slick scissors. In this part of the conversation, Matt Bennett discusses fly tying tools and accessories. He shares his personal preferences for whip finishers, dubbing brushes, and bobbins. He also discusses the importance of good-quality tools and recommends starting with a basic set. Matt and the hosts discuss the necessity of certain tools and accessories, such as a razor blade holder and a hair packer. They also talk about fly tying vises and Matt shares his favorite vise brands. Matt explains his process of production tying and how he organizes his materials. He also discusses the consistency of natural materials and the importance of sourcing them from reliable suppliers. The conversation concludes with discussing Matt's decision to stop tying commercially and his transition to working in the family forestry business. The conversation concludes with a game where the hosts and guests rank different fly tiers. The rankings are subjective and based on personal preferences. Matt Bennett shares stories about his interactions with some of the fly tiers on the list. He also mentions that he is not currently taking orders for flies but occasionally donates them for a good cause. The episode ends with a farewell and a reminder to follow Matt on Instagram.   Takeaways -Tying your flies may not necessarily save money, as fly tiers often end up buying a lot of materials and tools. -Starting a fly tying business requires a lot of dedication and hard work, and the business side of things can be challenging. -Designing new fly patterns involves experimentation and making modifications to existing patterns to suit specific fishing conditions. -Popular fly patterns, such as the Lunch Money and the Rio Getter, have gained recognition and success in the fly fishing community. -There is a finite number of materials available for fly tying, but the combination and design of those materials can create unique fly patterns. -Creating a new fly pattern involves more than just combining materials; it also requires designing the fly to act right and choosing the right colors. -Commercializing a fly pattern involves submitting prototypes to fly tying companies and going through a selection process. -When starting in fly tying, it is important to find a community or mentor who can provide guidance and support. -Investing in quality tools and materials can save a lot of frustration and lead to better results in fly tying. Having good quality fly tying tools is important for a consistent and enjoyable tying experience. -Starting with a basic set of tools is recommended for beginners. -Certain tools and accessories, such as a razor blade holder and a hair packer, may not be necessary for all types of flies. -Choosing the right fly tying vise depends on personal preference and the types of flies being tied. -Consistency in natural materials, such as rabbit zonker strips and marabou, can be achieved by sourcing them in bulk from reliable suppliers. -Matt transitioned from tying commercially to working in the family forestry business. -Rankings of fly tiers are subjective and based on personal preferences. -Interacting with and learning from different fly tiers can be a valuable experience.    

Smart Biotech Scientist | Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
52: Unraveling the Complexity of Commercializing Cell and Gene Therapies w/ Wajiha Ali - Part 2

Smart Biotech Scientist | Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists

Play Episode Listen Later May 9, 2024 25:41


Does the process of commercializing cell and gene therapies seem complex and unclear to you?Dive deep into the groundbreaking world of cell and gene therapies with our guest, Wajiha Ali, a strategy expert who believes in bridging the gap between research and commercialization with data, as we unravel the complexities of bringing life-saving therapies to patients.From cutting-edge technologies to innovative collaboration models, we explore the future landscape of these transformative treatments.You'll get:An understanding of how partnerships between academic centers, pharma companies, and regulators can decrease development costs and simplify commercialization, resulting in wider accessibility.An investigation into how data analytics, AI, and machine learning can transform supply chains, target selection, commercialization strategies, and regulatory frameworks.A discovery of new methods for equitable therapy access, such as outcome-based pricing, local manufacturing, and the growing role of digital platforms in patient advocacy.Join us on this insightful journey into the future of cell and gene therapies.Connect with Wajiha Ali:LinkedIn: https://www.linkedin.com/in/wajiha-ali-6468454X (Twitter): https://twitter.com/WajihaaliNext Step:Develop biologics and cell & gene therapies with peace of mind. Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

Mastering Medical Device
Commercializing a Disruptive Technology in a Hospital with Multiple Decision Makers and Influencers - Featuring Joe Steele

Mastering Medical Device

Play Episode Listen Later May 7, 2024 60:54 Transcription Available


Joe Steele is Head of Commercialization at Hemosonics, where they are providing point-of-care solutions to help clinicians make more informed decisions on blood product usage.   In this episode Joe shares  why moving up the ladder too fast may not be the best way to go, why experiencing failure will help in the long-run, how to use wisdom from past experiences and apply it to new situations, the challenges of hiring, training and managing a group of hard-charging people, getting into the C suite, and how Hemosonics is helping doctors make blood product usage decisions quicker and better.Links from this episode:Joe Steele LinkedIn https://www.linkedin.com/in/janthonysteele/Hemosonics  https://hemosonics.com/Support the Show.Connect with Mastering Medical Device: Website: https://www.masteringmedicaldevice.com LinkedIn: https://www.linkedin.com/company/mastering-medical-device Patrick Kothe LinkedIn: https://www.linkedin.com/in/patrick-kothe Patrick Kothe Twitter: https://twitter.com/patrickkothe Support the show for as little as $3/month: https://www.buzzsprout.com/1286645/support Thanks for listening!

Smart Biotech Scientist | Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
51: Unraveling the Complexity of Commercializing Cell and Gene Therapies w/ Wajiha Ali - Part 1

Smart Biotech Scientist | Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists

Play Episode Listen Later May 7, 2024 19:26


Are you finding the path to commercializing cell and gene therapies complex and uncertain?Join us as we explore this intricate landscape with our guest, Wajiha Ali. As a strategy expert who believes in bridging the gap between research and commericalization with data who she will guide us through the challenges, victories, and vital strategies for successfully bringing these cutting-edge therapies to market.Key Highlights:Discover the amplified complexity of cell and gene therapies, from patient referral hurdles to manufacturing site regulations.Explore the crucial commercialization strategies, infrastructure requirements, and the delicate balance between innovation and necessity.Unveil the regulatory scrutiny and stakeholder management intricacies, paving the way for safer, more accessible therapies.Tune in as we navigate the journey from scientific breakthroughs to real-world application, unraveling the complexities shaping the future of healthcare.Connect with Wajiha Ali:LinkedIn: https://www.linkedin.com/in/wajiha-ali-6468454X (Twitter): https://twitter.com/WajihaaliNext Step:Develop biologics and cell & gene therapies with peace of mind. Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment

FemInnovation
Ep. 17: Building a Femtech Product Commercialization Strategy

FemInnovation

Play Episode Listen Later Apr 18, 2024 36:22


Commercializing your femtech or healthtech product can be challenging, especially for early-stage founders. Bringing a product to market often involves detailed customer research and product testing, developing impactful launch and communication strategies, removing barriers to consumer adoption, identification of the proper reimbursement pathway, and more. In this episode of the FemInnovation Podcast, host Bethany Corbin sits down with Swathi Rangan and Daniella Kapural from Herspiegel to discuss the secrets for product commercialization success. The trio discusses what product commercialization means, when femtech founders should start thinking about a product commercialization strategy, common product commercialization mistakes, how to identify applicable business models, how to determine product differentiators and develop a value proposition, and much more! Don't miss this in-depth discussion to enhance your product commercialization strategy and experience.  About Swathi Rangan:As a Principal at Herspiegel, Swathi leverages her passion and expertise within the sciences and strong problem-solving skills to help pharmaceutical clients swiftly address complex business challenges. She excels at developing and leading teams to craft successful commercial solutions, in collaboration with the client.Throughout her tenure at Herspiegel, Swathi has led projects with a variety of clients, ranging from large to mid-size, and start-ups. She has deep knowledge in a variety of therapeutic areas including women's health, immunology, oncology, cardiometabolic disorders, and rare disease. Her expertise includes leading strategy and implementation across commercial projects with a strong focus on data and insight-driven innovation; projects include patient support and experience design, digital health partnership implementation, and go-to-market strategy development. She also specializes in creating comprehensive market-shaping strategies for complex disease states and has successfully managed numerous product launches.About Daniella Kapural: Daniella began her consulting career at Herspiegel with a fervent commitment to enhancing the patient experience through strategic problem-solving and innovation. During her tenure, she cultivated a passion for advancing women's health, focusing on devising solutions to address the diverse and complex healthcare needs unique to women across the continuum of care.As a Consultant, she has demonstrated exceptional leadership and support across a diverse array of projects, encompassing product launch, brand planning, go-to-market strategy development, digital health integration, and change management implementation. She serves a broad spectrum of clients, ranging from start-ups to established pharmaceutical giants, lending her expertise across various therapeutic areas such as women's health, oncology, cardiovascular disorders, and neurology. RELEVANT LINKS: More about Herspiegel at this website. Connect with Swathi Rangan on Linkedin. Connect with Daniella Kapural on LinkedIn. Follow Our Host, Bethany Corbin: WEBSITE | LINKEDIN | INSTAGRAM | ADDITIONAL LINKS

The Capital Stack
Nick Steinwachs of Tidal Digital Health Partners on Building Healthcare Products and Navigating Stakeholders

The Capital Stack

Play Episode Listen Later Apr 16, 2024 32:46


In this conversation, David Paul interviews Nick Steinwachs about the challenges and opportunities in the healthcare industry. They discuss the importance of customer empathy, the role of founders in healthcare startups, and the need for innovative solutions. They also touch on the difficulties of commercializing healthcare products and the importance of market validation. Nick shares his insights on finding a product-market fit and navigating founder bias. Overall, the conversation highlights the complexities of the healthcare industry and the importance of understanding customer needs. You can watch/listen to the podcast on YouTube, Spotify, and Apple.TakeawaysCustomer empathy and subject matter expertise are crucial in building successful healthcare products.Commercializing healthcare products can be challenging due to regulatory issues and the need for buy-in from healthcare providers.Shifting the market conversation can be more effective than trying to retool a product that is not resonating with customers.Founders should listen to their market and be willing to let go of their solutions to address the real problems.Market validation is important, and founders should focus on usability, feasibility, viability, and value in their product development process.Chapters00:00 Introduction and Background02:26 The Importance of Customer Empathy08:21 Challenges in Commercializing Healthcare Products14:51 Shifting the Market ConversationKeywords- healthcare, startups, customer empathy, product-market fit, commercialization, market validation, founder bias29:12 The Role of Market Validation

Over Quota
Turning A Career Frustration Into The Inspiration For A Startup with Kayvon Touran

Over Quota

Play Episode Listen Later Apr 15, 2024 58:38


In this episode I had the pleasure of speaking with Kayvon Touran, CEO and Co-Founder of Zal.ai. He shared how a career frustration he had inspired Zal which helps organizations implement career pathing and specifically to help them contextualize, apply and measure the efficacy of their learning and development programs.  That said, more than anything, this episode is about the start of an entrepreneurial journey and how to take an idea and see it through all the way to builing a product with a market and a strategy to sell it. Lots of leanings along the way.  Enjoy! Kayvons Linkedin Profile   The ideation phase (00:02:05) Kayvon's journey in early stage technology startups. The need for context in learning and development programs (00:03:19) Kayvon's realization of the context problem in workforce development and the need for personalized, dynamic, and applicable learning content. Challenges in career pathing implementation (00:05:25) The difficulties and opportunities in implementing career pathing, the value of career pathing, and its challenges in terms of cost and time. Creating alignment between strategic initiatives and career goals (00:07:11) The importance of creating alignment between an organization's strategic initiatives and employees' career goals, and the challenges faced in achieving this alignment. The messy process of ideation and information gathering (00:16:56) The chaotic process of gathering information, following instincts, and overcoming doubts during the ideation phase. Judging information and separating signal from noise (00:19:58) Kayvon's intuitive approach to processing information and the importance of combining different perspectives to determine the accuracy of the information. Resources for Research (00:21:40) Kayvon talks about the various resources used for research, including programs and homegrown research. Challenges in Job Architecture (00:25:33) Kayvon explains the challenges faced by companies in creating accurate job architecture and how Zol addresses these issues. Career Path Tool and Skill Verification (00:28:44) Kayvon details the features of the career path tool and the importance of skill verification in their platform. Staying Disciplined in Feature Development (00:30:54) Kayvon discusses the discipline required to avoid building unnecessary features and the focus on delivering value to users. Building the First AI MVP (00:31:29) Kayvon explains the process of creating the first AI minimum viable product and the value-driven approach to development. Customer Acquisition Strategy (00:37:40) Kayvon shares the strategy of building a community of interested individuals and incorporating customer feedback into the product development process. Pricing and Commercializing (00:40:39) Discussion on pricing strategies and challenges in quantifying the value of solutions for changing job dynamics. Iterative Process and Refinement (00:41:27) Emphasizing the iterative approach in developing the business, including pricing strategies and market positioning. Investing in Company Growth (00:45:38) Strategies for reinvesting in the company to enhance product offerings and expand the customer base. Target Market Segmentation (00:49:40) Segmenting the target market based on company size and tailoring offerings to specific audience and organizational needs.  

The Better. Cleaner. Now! Podcast
Commercializing CoverCress | The Better. Cleaner. Now! Podcast

The Better. Cleaner. Now! Podcast

Play Episode Listen Later Apr 10, 2024 28:59


More than 75 million farm acres in the U.S. currently don't use a cover crop. Michelle Starke, Director of Stewardship and Regulatory Affairs at CoverCress, and Alan Weber, Consultant to Clean Fuels and Founding Parter of MARC-IV, explain the benefits of producing a new feedstock that goes into renewable fuels. Discover how CoverCress, with its winter annual growth cycle, seamlessly integrates into existing corn and soybean rotations.For more information, visit Clean Fuels Alliance America. To suggest topics or guests for a future episode, email us at podcasts@CleanFuels.org.

This Week in Startups
Liquid AI's Ramin Hasani on liquid neural networks, AI advancement, the race to AGI & more! | E1928

This Week in Startups

Play Episode Listen Later Apr 9, 2024 63:36


This Week in Startups is brought to you by… LinkedIn Jobs. A business is only as strong as its people, and every hire matters. Go to LinkedIn.com/TWIST to post your first job for free. Terms and conditions apply. Experimentation is how generation-defining companies win. Accelerate your experimentation velocity with Eppo. Visit geteppo.com/twist Attio - A radically new CRM for the next era of companies. Head to attio.com/twist to get 15% off for your first year. * Todays show: Liquid AI's Ramin Hasani joins Jason to discuss the mission and the concept of Liquid AI's liquid neural networks (1:09). They dive into liquid neural networks' applications (16:07), transition from theory to execution (21:37), their efficiency on small devices (27:30), and more! * Timestamps: (0:00) Liquid AI CEO and co-founder Ramin Hasani joins Jason (1:09) Liquid AI's mission and concept of liquid neural networks (7:06) LinkedIn Jobs - Post your first job for free at https://linkedin.com/twist (8:34) Demo of Liquid AI: traditional vs. Liquid neural networks in autonomous driving (16:07) Practical applications of Liquid AI (20:07) Eppo. Accelerate your experimentation velocity with Eppo. Visit geteppo.com/twist (21:37) Commercializing worm-inspired AI systems, building a team, and solving problems across various sectors (27:30) Efficiency of liquid neural networks in compact devices like the Raspberry Pi and the transformative potential of AI modeled after worms. (34:15) Attio - Head to attio.com/twist to get 15% off for your first year. (35:24) Data ownership in AI and incentivizing data providers (41:18) Role of AI in real-world applications (43:57) Societal impact of AI, job displacement, and the optimistic view on AI's potential (50:25) Explanation of physical models vs statistical models in AI and the challenge of understanding black box AI systems (57:01) Speculations about AGI's market cap, who might achieve AGI first, and the potential of using AI systems to build various applications (1:00:12) Comparison between open-source and closed-source models in AI and the trend of open-source moves in the AI industry * Mentioned on the show: https://www.raspberrypi.com/products/raspberry-pi-5 https://www.capgemini.com/us-en https://www.ctc-g.co.jp/en https://www.accenture.com https://www.ey.com/en_gl https://www.cnn.com/videos/media/2024/04/02/the-daily-show-jon-stewart-ai-work-force-jobs-orig.cnn * Source of C. elegans worm footage: https://www.youtube.com/watch?v=zjqLwPgLnV0&t=1s * Follow Ramin: X: https://twitter.com/ramin_m_h LinkedIn: https://www.linkedin.com/in/raminhasani Check out Liquid AI: https://www.liquid.ai * Follow Jason: X: https://twitter.com/Jason LinkedIn: https://www.linkedin.com/in/jasoncalacanis * Subscribe to This Week in Startups on Apple: https://rb.gy/v19fcp * Thank you to our partners: (7:06) LinkedIn Jobs - Post your first job for free at https://linkedin.com/twist (20:07) Eppo. Accelerate your experimentation velocity with Eppo. Visit geteppo.com/twist (34:15) Attio - Head to attio.com/twist to get 15% off for your first year. * Great 2023 interviews: Steve Huffman, Brian Chesky, Aaron Levie, Sophia Amoruso, Reid Hoffman, Frank Slootman, Billy McFarland * Check out Jason's suite of newsletters: https://substack.com/@calacanis * Follow TWiST: Substack: https://twistartups.substack.com Twitter: https://twitter.com/TWiStartups YouTube: https://www.youtube.com/thisweekin Instagram: https://www.instagram.com/thisweekinstartups TikTok: https://www.tiktok.com/@thisweekinstartups * Subscribe to the Founder University Podcast: https://www.founder.university/podcast

Slip The Jab
Episode 199: Imavov vs. Dolidze Recap • Hermansson vs. Pyfer Preview • STJ 200th Special Cocktail Program • Commercializing Love

Slip The Jab

Play Episode Listen Later Feb 7, 2024 221:17


Support the showALSO AVAILABLE ON:Spotify: https://tinyurl.com/STJSpotifyApple Podcasts: https://tinyurl.com/STJApplePodcastsFOLLOW US ON SOCIAL MEDIA:Twitter: https://twitter.com/slipthejabpodSponsored by NuKine WellnessUse code SLIPSTER20 for 20% OFF

The CleanTechies Podcast
#152 Policy x IRA, Carbon Capture, Commercializing DeepTech, Hardware Headwinds & More w/ Adam Goff (8 Rivers)

The CleanTechies Podcast

Play Episode Listen Later Feb 1, 2024 46:05 Transcription Available


Today, we are joined by Adam Goff, the SVP of Strategy at 8 Rivers, a technology portfolio developer. Think of it like a venture studio but specifically for technology (often chemistry) instead of companies.(Take the CleanTechies Listeners Survey to help us better serve you) He talks us through how that looks and how they commercialize the products, and we also spend a lot of time discussing the role and importance of policy when it comes to clean tech. Enjoy the episode!

Selling Jesus
Deep Dive into 2 Corinthians 2:17 - Commercializing the Word of God

Selling Jesus

Play Episode Listen Later Jan 18, 2024 22:58


Read the article here. "For we are not, like so many, peddlers of God's word, but as men of sincerity, as commissioned by God, in the sight of God we speak in Christ" (2 Cor. 2:17, ESV). This highly technical discussion is not an easy listen, and it's recommended that you complement it with the visuals in the written version of the article. That said, the primary source of interest in this verse is the word translated by the ESV as “peddlers” (καπηλεύοντες, from καπηλεύω). Commentators and translations divide over recognizing this word as indicating an adulteration or commercialization of the gospel. Furthermore, they differ on whether or not this word necessarily implies a motive of profit. Thus, as we will see below, some translations add “for profit” to the verse because they believe it to be implicit information from the context that needs to be made explicit to the reader, even though the words “for profit” are not found in the Greek. This matters because there are those who would argue that 2 Corinthians 2:17 does not confront the Jesus trade, but rather speaks merely of those who make too much profit from selling Jesus. Or they claim that this verse has nothing to do with selling, but rather with "corrupting" God's Word. Is there really a loophole here for Jesus sellers to avoid Paul's condemnation, or does it simply mean: "we are not commercializing God's Word like so many others"? sellingjesus.org⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠thedoreanprinciple.org⁠⁠⁠⁠⁠⁠ | ⁠⁠⁠⁠⁠⁠copy.church

The Vertical Space
#57 Valerie Manning, Overair: Reality Check On Commercializing eVTOLs

The Vertical Space

Play Episode Listen Later Jan 3, 2024 72:23 Transcription Available Very Popular


Welcome to our conversation with Dr. Valerie Manning, Chief Commercial Officer of Overair. This is a discussion around the value of advanced air mobility, of eVTOLs and Overair's unique value to meet these requirements. We've had this discussion many times, on the value of the advanced air mobility and eVTOLs, but it changes over time and of course, based on the experience, education and the workplace of the person responding. And so as such, this is a conversation with Valerie that's really worth listening to. We discussed the state of advanced air mobility market today compared to several years ago, the most notable milestones, what's not getting enough attention and the road to commercialization. We then discuss what has changed about the viability and the use case of eVTOLs  in the last several years, both positive and otherwise. We spend a bit of time discussing whether or not there's a real first mover advantage  in advanced air mobility, comparing Boeing's potential advantage in the early days of aviation and perhaps where Overair may have a slow mover advantage as their vehicle will learn from the experiences and the learning curve of the initial launch vehicles and early stage eVTOL markets. We then discussed Valerie's work as Chief Commercial Officer, what the role entails a bit about their go to market strategy, and a more detailed discussion around the trade-off between selling aircraft and operating transportation networks. 

Three Cartoon Avatars
EP 86: Christian Chabot (Co-Founder Tableau) on Operating Lessons From Scaling Tableau to $15.7B

Three Cartoon Avatars

Play Episode Listen Later Nov 10, 2023 114:32


(0:00) Intro(0:55) Christian's Early Career and Entrepreneurial Journey(3:14) Finding an opportunity in the market(6:12) Joining SoftBank(7:14) Lessons on venture capital(10:50) Company origin stories(12:03) The Birth of Tableau: From Idea to Company(16:20) Getting right in the early days(20:55) Commercializing something out of academia(23:42) Bootstrapping it(28:23) The growth and success of Tableau(32:38) Reflections on the journey and the future(43:57) Patience and basic metrics in business growth(45:33) The role of external investors in business expansion(48:02) The impact of capital on business ambitions and control(49:38) Choosing the right investor(51:39) The importance of maintaining control in fundraising(54:11) Competition in business growth(58:28) The importance of team chemistry in scaling a business(1:02:19) Impact of disruptive hiring practices on business growth(1:21:26) Power of community and innovating marketing(1:26:16) Global expansion Produced: Rashad Assir & Leah ClapperMixed and edited: Justin HrabovskyExecutive Producer: Josh Machiz 

.NET Rocks!
Commercializing Open Source with Victoria Melnikova

.NET Rocks!

Play Episode Listen Later Nov 9, 2023 49:00


How do you commercialize open-source products? While at NDC Porto, Carl and Richard talked to Victoria Melnikova about her work with Evil Martians, helping startups make open-source products and make a living at the same time. Victoria talks about various revenue strategies, but always with a mind to providing a "forever free" tier to be responsible to the open source community. Charging for pro-features, limiting the number of uses before a paid tier... there are several approaches to revenue that users can work with, as long as you are open and honest about how things work!

Between Two COO's with Michael Koenig
Prisma COO, Nitin Gupta, explains tech to my mom, operationalizing hackathons, the balance of commercializing open-source, planning, and a team psychologist

Between Two COO's with Michael Koenig

Play Episode Listen Later Sep 26, 2023 45:03


Unlock the secrets of remote team management and product explanation in our stimulating conversation with Nitin Gupta, the COO of Prisma. Nitin unveils how explaining technical products to non-technical people can be a challenge, but he makes it understandable, going as far as breaking down Prisma into simple terms for our mothers. Also, learn about Prisma University, a unique internal initiative to educate non-tech team members about their product's nuances. Beyond product explanation, we venture into the world of remote hackathons and the operational challenges within. Nitin highlights anticipating potential issues within a remote team and the significance of aligning all-hands meetings with the organization's structure. More so, we explore Prisma's unique take on transparency and collaboration as they open-source their processes. Finally, we delve into the less conventional aspects of managing a remote company. Nitin shares insights on why they hired a trained psychologist for HR and how it helps prevent employee burnout. He also unveils an interesting balance between commercializing open-source projects and maintaining a vibrant community through the 123 framework. Additionally, we discuss operational execution, aligning teams to KPIs, and Nitin's unique approach to quarterly planning. This episode is a must-listen for tech enthusiasts and remote team managers looking for practical tips and fascinating insights. (0:00:13) - Explaining Prisma and Building Knowledge SharingNitin Gupta explains Prisma to his mother, Prisma University educates internally, and technical team members share knowledge. (0:11:13) - Remote Hackathon and Organizational Structure ManagementNitin Gupta discusses hackathon operationalization, remote team issues, all hands meetings, organization structure, and open sourcing processes. (0:18:40) - Psychologists and Open Source in Remote CompaniesNitin Gupta emphasizes HR with psychologist hire, uses 123 framework to balance open source project and community vibrancy. (0:35:30) - Operational Execution and Alignment of KPIsNitin Gupta discusses aligning teams to KPIs, concentrating on company-wide objectives, quarterly planning, and negotiating with a mobile handset manufacturer. Episode link: https://betweentwocoos.com/prisma-coo-nitin-guptaNitin Gupta: https://www.linkedin.com/in/gnitingMichael Koenig: https://www.linkedin.com/in/michael-koenig514/ 

Planet MicroCap Podcast | MicroCap Investing Strategies
BioSyent (TSX-V: RX): Specialty Pharmaceutical Company Focused on Commercializing Assets in Canada

Planet MicroCap Podcast | MicroCap Investing Strategies

Play Episode Listen Later Sep 19, 2023 57:57


My guest on the show today is Rene Goehrum, President, CEO and Chairman of BioSyent (TSX-V: RX). BioSyent is a specialty pharmaceutical company focused on commercializing products that the company says provides a distinguishable benefit to patients and their healthcare providers and, according to their website, is known for their ability to effectively and efficiently introduce new products to the Canadian market. BioSyent is, as the company states on their website, actively sought out as the Canadian market partner of choice by brand innovators with niche or specialty products looking for a trusted partner. The first time we interviewed Rene was back in June 2013. At the beginning of June 2013, the stock was trading around $1.30, and as of recording of this introduction, the morning of September 15, 2023, the stock closed at $7.85. Furthermore, as of Q2 2023, the company has reported 52 consecutive profitable quarters, according to their Q2 2023 results presentation. Many of you listening know the BioSyent story well, and yet despite the company's performance during Rene's tenure, I think some of you would agree that BioSyent is the most well-known unknown company. I thought it was time for folks that don't know the company's history and where they were going to have Rene on the show to chat about all of that, plus: Capital allocation discipline and approach Criteria for in-licensing new products, and; Rene's "promised land" / long-term vision for BioSyent With that, please enjoy my conversation with Rene Goehrum, President, CEO and Chairman of BioSyent. For more information about BioSyent, please visit: http://www.biosyent.com/rx/home/ This podcast was recorded and is being made available by SNN, Inc. (together with its affiliates and its and their employees, “SNN”) solely for informational purposes. SNN is not providing or undertaking to provide any financial, economic, legal, accounting, tax, or other advice in or by virtue of this podcast. The information, statements, comments, views, and opinions provided in this podcast are general in nature, and such information, statements, comments, views, and opinions, and the viewing of/listening to this podcast are not intended to be and should not be construed as the provision of investment advice by SNN. The information, statements, comments, views, and opinions expressed in this podcast do not constitute and should not be construed as an offer to buy or sell any securities or to make or consider any investment or other course of action. The information, statements, comments, views, and opinions expressed in this podcast (including by guest speakers who are not officers, employees, or agents of SNN) are not necessarily those of SNN and may not be current. Reference to any specific third-party entity, product, service, materials, or content does not constitute an endorsement or recommendation by the SNN. SNN assumes no responsibility or liability for the accuracy or completeness of the content contained in third party materials or on third party sites referenced in this podcast or the compliance with applicable laws of such materials and/or links referenced herein. The views expressed by guest speakers are their own and their appearance on this podcast does not imply an endorsement of them or any entity they represent. SNN does not make any representation or warranty as to the accuracy or completeness of any of the information, statements, comments, views, or opinions contained in this podcast, which may include forward-looking statements where actual results may differ materially. SNN does not undertake any obligation whatsoever to provide any form of update, amendment, change, or correction to any of the information, statements, comments, views or opinions set forth in this podcast. SNN EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES ARISING OUT OF ANY INDIVIDUAL'S USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE, THIS PODCAST OR THE INFORMATION PRESENTED IN THIS PODCAST. By accessing this podcast, the listener acknowledges that the entire contents and design of this podcast, are the property of SNN, or used by SNN with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this podcast may save and use information contained in the podcast only for personal or other non-commercial educational purposes. No other use, including without limitation, reproduction, retransmission, or editing of this podcast may be made without the prior written consent of SNN.

The Road to Autonomy
Episode 155 | Volvo Autonomous Solutions Commercialization Strategy, A Conversation with Nils Jaeger

The Road to Autonomy

Play Episode Listen Later Sep 5, 2023 41:02


Nils Jaeger, President, Volvo Autonomous Solutions, Volvo Group joined Grayson Brulte on The Road to Autonomy podcast to discuss Volvo Autonomous Solutions commercialization strategy. The conversation begins with Nils discussing how the Volvo Group is approaching autonomy. It's about leveraging autonomous tech for productivity gains, for efficiency gains. – Nils JaegerVolvo Autonomous Solutions is operating in the quarry and mining, ports and logistics and hub-to-hub sectors. These sectors were chosen as they compliment each other and are viewed as long-term growth markets. As a stand-alone business area inside of Volvo Group, Volvo Autonomous Solutions has full development responsibility and are responsible for the commercialization of Volvo Group's autonomous solutions. Being structured this way, means Volvo Autonomous Solutions has full P&L responsibility. With P&L responsibility, Nils and the team at Volvo Autonomous Solutions are focused on building a business.For us it's not just the technology, it's building a business. Building a business is really the core reason why Volvo Autonomous Solutions was created. Having a clear focus on commercialization and having an attractive business model. – Nils JaegerThe commercial business model for Volvo Autonomous Solutions is not a one-size fits all model. It's a model that is tailored to each one of the sectors where they operate. In the Dallas Fort-Worth region, Volvo Autonomous Solutions will be operating a hub-to-hub autonomous transport solution as a service. Commercializing the hub-to-hub autonomous transport business will require partnerships. As part of the initial roll-out, Volvo Autonomous Solutions has partnered with DHL and Uber Freight. To prepare for autonomous operations, Volvo has begun hauling freight manually in the Texas Triangle. We have actually started this year to pull loads manually for both DHL and Uber Freight. We are putting in place all of the procedures, the processes which are needed to develop this new transportation value chain and to do this of-course in a safe and reliable form. – Nils JaegerFrom a truck asset perspective, Volvo Group is going to own the autonomous trucks on their balance sheet as the service begins commercialization. In these early days there will not be a minimum amount of volume needed to tap into the service, however the volume will have to make economic sense. Wrapping up the conversation, Nils discusses the driver-out fully autonomous operations at the Brönnöy Kalk mine in Velfjord, Norway.Chapters:0:00 The Road to Autonomy Index0:56 The Road to Autonomy Introduction 1:23 Volvo Group's Approach to Autonomy 7:14 Volvo Autonomous Solutions Commercial Business Model17:33 Volvo Autonomous Solutions Terminal (Hub) Strategy21:16 Autonomous Truck Assets & Virtual Driver Strategy24:22 Economics of Volvo Autonomous Solutions Transport as a Service Model 27:57 Volvo Autonomous Solutions Quarry & Mining Business 35:20 The Future of Autonomy Recorded on Thursday, August 22, 2023--------About The Road to AutonomyThe Road to Autonomy® is a leading source of data, insight and commentary on autonomous vehicles and logistics. The company has three businesses: The Road to Autonomy Indices, with Standard and Poor's Dow Jones Indices as the custom calculation agent; Media, which includes The Road to Autonomy Podcast and The Road to Autonomy's This Week In The Index; and The Road to Autonomy Research and Consulting Services.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Integrate & Ignite Podcast
463: From Postdoc to CEO: Commercializing Science and Building a Biotech Startup with Lyndsey Linke of SiVEC

Integrate & Ignite Podcast

Play Episode Listen Later Aug 15, 2023 33:50


From postdoc to CEO of SiVEC, Lyndsey Linke's journey is one of relentless determination and groundbreaking discoveries. Listen to this episode of the Integrate & Ignite Marketing Podcast with host Lori Jones and learn about commercializing science, the power of innovation, the intersection of science and business, and all about her “napkin moment.”